Polku Therapeutics
PrivateLast Round
Grant
Jan 31, 2025
Total Funding Raised
$2.56M
Company Overview
Polku Therapeutics is a biotechnology company that develops first-in-class small-molecule therapies targeting the PREP–PP2A pathway to treat neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, and frontotemporal dementia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Polku Therapeutics Comparables
Compare Polku Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeurOdys Therapeutics | 84% | |
| Treventis Corporation | 78% | |
| Asceneuron | 77% |
Polku Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 31, 2025 | ||||
| Pre Seed | Sep 17, 2024 |
Polku Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovestor | Pre Seed |
| Rainwater Charitable Foundation | Grant |
| Helsinki University Funds | Pre Seed |
| Business Finland | Pre Seed |
| Torrey Pines Investment LLC | Pre Seed |
| Alzheimer's Association | Grant |
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 31, 2025
$330K from Rainwater Charitable Foundation and Alzheimer's Association.
- Sep 17, 2024
$2.34M round led by Torrey Pines Investment and Innovestor.
Polku Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access